CG:603392 Beijing Wantai Biological Pharmacy

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China.

226.00 CNY
As of 01/19/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  China
IPO date:  04/29/2020
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   139,910,578,176 CNY
Current dividend yield:   0.08%
Sedol:      BMXTWX4

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy